Mucosally delivered E1-deleted adenoviral vaccine carriers induce transgene product-specific antibody responses in neonatal mice

Journal of Immunology

Volumn 171, Issue 8, 2003, Pages 4287-4293

  Xiang, Zhiquan ^a   Li, Yan ^a   Gao, Guangping ^b   Wilson, James M ^b   Ertl, Hildegund C J ^a,b  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GENE PRODUCT; NEUTRALIZING ANTIBODY; RABIES VACCINE; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MALE; MOUSE; MUCOSAL IMMUNITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RABIES; SERUM; TRANSGENE; VACCINATION; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT;

EID: 0141958135     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.8.4287     Document Type: Article

References (44)

1. Kovarik, J., X. Martinez, and C.-A. Siegrist. 2003. The use of DNA vaccines for neonatal/early life childhood immunization. In DNA Vaccines. H. Ertl. ed. Kluwer. New York, pp. 241-262.
2. Spencer, J., and T. T. MacDonald. 1990. Ontogeny of human mucosal immunity. In Ontogeny of the Immune System of the Gut. T. T. MacDonald, ed. CRC, Boca Raton, pp. 23-50.
3. Nelson, D. J., C. McMenamin, A. S. McWilliam. M. Brenan, and P. G. Holt. 1994. Development of the airway intraepithelial dendritic cell network in the rat from class II major histocompatibility (Ia)-negative precursors: differential regulation of Ia expression at different levels of the respiratory tract. J. Exp. Med. 179:203.
4. Griebel, P. J., and W. R. Hein. 1996. Expanding the role of Peyer's patches in B-cell ontogeny. Immunol. Today 17:30.
5. MacIntyre, C. R. 2001. Hepatitis B vaccine: risks and benefits of universal neonatal vaccination. J. Paediatr. Child Health 37:215.
6. Ryan, M., L. Gothefors, J. Storsaeter, and K. H. Mills. 1997. Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice. Dev. Biol. Stand. 89:297.
7. Xiang, Z. Q., and H. C. Ertl. 1992. Transfer of maternal antibodies results in inhibition of specific immune responses in the offspring. Virus Res. 24:297.
8. Wang, Y., Z. Xiang, S. Pasquini, and H. C. Ertl. 1996. Immune responses to neonatal genetic immunization. Virology 228:278.
9. Bot, A., M. Shearer, S. Bot, M. Avriette, A. Garcia-Sastre, G. White, C. Woods, R. Kennedy, and C. Bona. 2001. Induction of immunological memory in baboons primed with DNA vaccine as neonates. Vaccine 19:1960.
10. Hassett, D. E., J. Zhang, M. Slifka, and J. L. Whitton. 2000. Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization. J. Virol. 74:2620.
11. Wang, Y., Z. Q. Xiang, S. Pasquini, and H. C. Ertl. 1997. The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus. J. Virol. 71:3677.
12. Farina, S. F., G. Gao, Z. Q. Xiang, J. J. Rux, R. M. Burnett. M. R. Alvira, J. Marsh, H. C. Ertl, and J. M. Wilson. 2001. Development of a replication-defective vector based on a chimpanzee adenovirus. J. Virol. 75:11603.
13. Basnight, M., Jr., N. G. Rogers, C. J. Gibbs, Jr., and D. C. Gajdusek. 1972. Characterization of four new adenovirus serotypes isolated from chimpanzee tissue explants. Am. J. Epidemiol. 94:166.
14. Xiang, Z. Q., G. Gao, A. Reyes-Sandoval, C. J. Cohen, Y. Li, J. M. Bergelson, J. M. Wilson, and H. C. Ertl. 2002. Novel, adenoviral vaccine carrier based on the chimpanzee serotype 68 for induction of antibodies to a transgene product. J. Virol. 76:2667.
15. Xiang, Z. Q., Y. Yang, J. M. Wilson, and H. C. Ertl. 1996. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219:220.
16. Wiktor, T. J., B. Dietzschold, R. N. Leamnson, and H. Koprowski. 1977. Induction and biological properties of defective interfering particles of rabies virus. J. Virol. 21, 626.
17. Morimoto, K., D. C. Hooper, S. Spitsin, H. Koprowski, and B. Dietzschold. 1999. Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J. Virol. 73:510.
18. Xiang, Z. Q., S. Pasquini, and H. C. Ertl. 1999. Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant. J. Immunol. 162:6716.
19. Xiang, Z. Q., S. Spitalnik, M. Tran, W. H. Wunner, J. Cheng, and H. C. Ertl. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132.
20. Dietzschold, B., M. Tollis, M. Lafon, W. H. Wunner, and H. Koprowski. 1987. Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies. Virology 16:29.
21. Ridge, J. P., E. J. Fuchs. and P. Matzinger. 1996. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271:1723.
22. Sarzottii, M. D., D. S. Robbins, and P. M. Hoffman. 1996. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 271:1726.
23. Forsthuber, T., H. C. Yip, and P. V. Lehmann. 1996. Induction of TH1 and TH2 immunity in neonatal mice. Science 271:1728.
24. Mor, G., G. Yamshchikov, M. Sedegah, M. Takeno, R. Wang, R. A. Houghten, S. Hoffman, and D. M. Klinman. 1996. Induction of neonatal tolerance by plasmid DNA vaccination of mice. J. Clin. Invest. 98:2700.
25. Gardner, M. J., D. L. Doolan, R. C. Hedstrom, R. Wang, M. Sedegah, R. A. Gramzinski, J. C. Aguiar, H. Wang, M. Margalith, P. Hobart. and S. L. Hoffman. 1996. DNA vaccines against malaria: immunogenicity and protection in a rodent model. J. Pharm. Sci. 85:1294.
26. Ishii, K. J., W. R. Weiss, and D. M. Klinman. 1999. Prevention of neonatal tolerance by a plasmid encoding granulocyte-macrophage colony stimulating factor. Vaccine 18:703.
27. Byun, D. G., C. E. Demeure, L. P. Yang, U. Shu, H. Ishihara, N. Vezzio, M. K. Gately, and G. Delespesse. 1994. In vitro maturation of human neonatal CD8 T lymphocytes into IL-4 and IL-5 producing cells. J. Immunol. 153:4862.
28. Wu, C. Y., C. Demeure, M. Kiniwa, M. Gately, and G. Delespesse. 1993. IL-12 induces the production of IFN-γ by neonatal human CD4 T cells. J. Immunol. 151:1938.
29. Brysen, Y. J., H. S. Winter, and S. E. Gard. 1980. Deficiency of immune interferon production by leukocytes of normal newborns. Cell Immunol. 55:191.
30. Nossal, G. L. V. 1996. Choices following antigen entry: antibody formation or immunological tolerance. Annu. Rev. Immunol. 13:1.
31. Cuff, C. F., D. C. Hooper, D. Kramer, D. H. Rubin, and J. J. Cebra. 1992. Functional and phenotypic analyses of the mucosal immune response in mice: approaches to studying the immunogenicity of antigens applied by the enteric route. Vaccine Res. 1:175.
32. Sheridan, J. F., R. S. Eydelloth, S. L. Vonderfect, and L. Aurelian. 1983. Virus specific immunity in neonatal and adult mouse rotavirus infection. Infect. Immun. 39:917.
33. Zhong, L., A. Granelli-Piperno, Y. Choi, and R. M. Steinman. 1999. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Eur. J. Immunol. 29:964.
34. Varnavski, A. N., K. Schlienger, J. M. Bergelson, G. P. Gao, and J. M. Wilson. Efficient transduction of human monocytes-derived dendritic cells by chimpanzee-derived adenoviral vector. Hum. Gene Ther. 14:533.
35. Morelli, A. E., A. T. Larregina, R. W. Ganster, A. F. Zahorchak, J. M. Plowey, T. Takayamam, A. J. Logar, P. D. Robbins, L. D. Falo, and A. W. Thomson. 2000. Recombinant adenovirus induces maturation of dendritic cells via an NF-κB-dependent pathway. J. Virol. 74:9617.
36. Kobayashi, K., L. D. Hernandez, J. E. Galan, C. A. Janeway, Jr., R. Medzhitov, and R. A. Flavel. 2002. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110:191.
37. Zhang, Y., N. Chirmule, G. P. Gao, R. Qian, M. Croyle, B. Joshi, J. Tazelaar, and J. M. Wilson. 2001. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol. Ther. 3:697.
38. St George, J. A. 2003. Gene therapy progress and prospects: adenoviral vectors. Gene Ther. 10:1135.
39. Mannick, E., and J. N. Udall, Jr. 1996. Neonatal gastrointestinal mucosal immunity. Clin. Perinatol. 23:287.
40. Husband. A. J., M. R. Brandon, and A. K. Lascelles. 1973. The effect of corticosteroid on absorption and endogenous production of immunoglobulins in calves. Aust. J. Exp. Biol. Med. Sci. 51:707.
41. Belyakov, I. M., B. Moss, W. Strober, and J. A. Berzofsky. 1999. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity. Proc. Natl. Acad. Sci. USA 96:4512.
42. Mantis, N. J., M. C. Cheung, K. R. Chintalacharuvu, J. Rey, B. Corthesy, and M. R. Neutra. 2002. Selective adherence of IgA to murine patch M cells: evidence for a novel IgA receptor. J. Immunol. 169:1844.
43. Pasetti, M. F., E. M. Barry, G. Losonsky, M. Singh, S. M. Medina-Moreno, J. M. Polo, J. Ulmer, H. Robinson, M. B. Sztein. and M. M. Levine. 2003. Attenuated Salmonella enterica serovar typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats. J. Virol. 77:5209.
44. Xiang, Z. Q., G. P. Gao, A. Reyes-Sandoval, Y. Li, J. M. Wilson, and H. C. J. Ertl. 2003. Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier. J. Virol. In press.